Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Functional Interaction of Hypoxia-Inducible Factor 2-Alpha and Autophagy Mediates Drug Resistance in Colon Cancer Cells.

Saint-Martin A, Martínez-Ríos J, Castañeda-Patlán MC, Sarabia-Sánchez MA, Tejeda-Muñoz N, Chinney-Herrera A, Soldevila G, Benelli R, Santoyo-Ramos P, Poggi A, Robles-Flores M.

Cancers (Basel). 2019 May 30;11(6). pii: E755. doi: 10.3390/cancers11060755.

2.

Human Gut-Associated Natural Killer Cells in Health and Disease.

Poggi A, Benelli R, Venè R, Costa D, Ferrari N, Tosetti F, Zocchi MR.

Front Immunol. 2019 May 3;10:961. doi: 10.3389/fimmu.2019.00961. eCollection 2019. Review.

3.

Beta-tricalcium phosphate ceramic triggers fast and robust bone formation by human mesenchymal stem cells.

Pereira RC, Benelli R, Canciani B, Scaranari M, Daculsi G, Cancedda R, Gentili C.

J Tissue Eng Regen Med. 2019 Jun;13(6):1007-1018. doi: 10.1002/term.2848. Epub 2019 Apr 15.

PMID:
30811859
4.

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.

Costa D, Venè R, Benelli R, Romairone E, Scabini S, Catellani S, Rebesco B, Mastracci L, Grillo F, Minghelli S, Loiacono F, Zocchi MR, Poggi A.

Front Immunol. 2018 May 29;9:1150. doi: 10.3389/fimmu.2018.01150. eCollection 2018.

5.

Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapy.

Benelli R, Venè R, Ferrari N.

Transl Res. 2018 Jun;196:42-61. doi: 10.1016/j.trsl.2018.01.003. Epub 2018 Feb 2. Review.

PMID:
29421522
6.

The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.

Brizzolara A, Benelli R, Venè R, Barboro P, Poggi A, Tosetti F, Ferrari N.

Cancer Lett. 2017 Aug 1;400:9-17. doi: 10.1016/j.canlet.2017.04.025. Epub 2017 Apr 25.

PMID:
28450158
7.

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.

Zocchi MR, Costa D, Venè R, Tosetti F, Ferrari N, Minghelli S, Benelli R, Scabini S, Romairone E, Catellani S, Profumo A, Poggi A.

Oncoimmunology. 2017 Jan 6;6(3):e1278099. doi: 10.1080/2162402X.2016.1278099. eCollection 2017.

8.

A humanized system to expand in vitro amniotic fluid-derived stem cells intended for clinical application.

Martinelli D, Pereira RC, Mogni M, Benelli R, Mastrogiacomo M, Coviello D, Cancedda R, Gentili C.

Cytotherapy. 2016 Mar;18(3):438-51. doi: 10.1016/j.jcyt.2015.11.020.

PMID:
26857233
9.

NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, Benelli R, Spaggiari GM, Cantoni C, Campana S, Bonaccorsi I, Morandi B, Truini M, Mingari MC, Moretta L, Ferlazzo G.

Nat Commun. 2015 Sep 23;6:8280. doi: 10.1038/ncomms9280.

PMID:
26395069
10.

Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.

Venè R, Tosetti F, Minghelli S, Poggi A, Ferrari N, Benelli R.

Oncotarget. 2015 May 20;6(14):12310-25.

11.

Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.

Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F.

Neoplasia. 2014 Sep;16(9):710-22. doi: 10.1016/j.neo.2014.07.012.

12.

Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Giannoni P, Pietra G, Travaini G, Quarto R, Shyti G, Benelli R, Ottaggio L, Mingari MC, Zupo S, Cutrona G, Pierri I, Balleari E, Pattarozzi A, Calvaruso M, Tripodo C, Ferrarini M, de Totero D.

Haematologica. 2014 Jun;99(6):1078-87. doi: 10.3324/haematol.2013.091405. Epub 2014 Feb 21.

13.

Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution.

Pereira RC, Scaranari M, Benelli R, Strada P, Reis RL, Cancedda R, Gentili C.

Tissue Eng Part A. 2013 Jun;19(11-12):1476-88. doi: 10.1089/ten.TEA.2012.0225.

PMID:
23360471
14.

Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell.

Benelli R, Stigliani S, Minghelli S, Carlone S, Ferrari N.

Prostate. 2013 Jun;73(9):941-51. doi: 10.1002/pros.22640. Epub 2013 Jan 17.

PMID:
23334998
15.

A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.

Puntoni M, Branchi D, Argusti A, Zanardi S, Crosta C, Meroni E, Munizzi F, Michetti P, Coccia G, De Roberto G, Bandelloni R, Turbino L, Minetti E, Mori M, Salvi S, Boccardo S, Gatteschi B, Benelli R, Sonzogni A, DeCensi A.

Cancer Prev Res (Phila). 2013 Feb;6(2):74-81. doi: 10.1158/1940-6207.CAPR-12-0249. Epub 2012 Dec 4.

16.

Celecoxib induces proliferation and Amphiregulin production in colon subepithelial myofibroblasts, activating erk1-2 signaling in synergy with EGFR.

Benelli R, Venè R, Minghelli S, Carlone S, Gatteschi B, Ferrari N.

Cancer Lett. 2013 Jan 1;328(1):73-82. doi: 10.1016/j.canlet.2012.09.008. Epub 2012 Sep 23.

PMID:
23010081
17.

Xanthohumol impairs human prostate cancer cell growth and invasion and diminishes the incidence and progression of advanced tumors in TRAMP mice.

Venè R, Benelli R, Minghelli S, Astigiano S, Tosetti F, Ferrari N.

Mol Med. 2012 Dec 6;18:1292-302. doi: 10.2119/molmed.2012.00174.

18.

The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration.

Benelli R, Venè R, Ciarlo M, Carlone S, Barbieri O, Ferrari N.

Biochem Pharmacol. 2012 Jun 15;83(12):1634-42. doi: 10.1016/j.bcp.2012.03.006. Epub 2012 Mar 17.

PMID:
22445931
19.

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, Solari N, Gualco M, Queirolo P, Moretta L, Mingari MC.

Cancer Res. 2012 Mar 15;72(6):1407-15. doi: 10.1158/0008-5472.CAN-11-2544. Epub 2012 Jan 18.

20.

Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.

Ciarlo M, Benelli R, Barbieri O, Minghelli S, Barboro P, Balbi C, Ferrari N.

Int J Cancer. 2012 Aug 1;131(3):582-90. doi: 10.1002/ijc.26402. Epub 2011 Oct 20. Erratum in: Int J Cancer. 2014 Nov 1;135(9):E9.

21.

Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.

Del Grosso F, Coco S, Scaruffi P, Stigliani S, Valdora F, Benelli R, Salvi S, Boccardo S, Truini M, Croce M, Ferrini S, Longo L, Tonini GP.

Mol Cancer Res. 2011 Jul;9(7):815-23. doi: 10.1158/1541-7786.MCR-10-0367. Epub 2011 Jun 3.

22.

The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability.

Benelli R, Monteghirfo S, Venè R, Tosetti F, Ferrari N.

Mol Cancer. 2010 Jun 10;9:142. doi: 10.1186/1476-4598-9-142.

23.

Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.

Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, Foti M.

J Hepatol. 2009 Jun;50(6):1132-41. doi: 10.1016/j.jhep.2009.01.027. Epub 2009 Apr 1.

PMID:
19398230
24.

Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player.

Benelli R, Monteghirfo S, Balbi C, Barboro P, Ferrari N.

Int J Cancer. 2009 Jun 15;124(12):2989-96. doi: 10.1002/ijc.24305.

25.

Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.

Bianco R, Rosa R, Damiano V, Daniele G, Gelardi T, Garofalo S, Tarallo V, De Falco S, Melisi D, Benelli R, Albini A, Ryan A, Ciardiello F, Tortora G.

Clin Cancer Res. 2008 Aug 15;14(16):5069-80. doi: 10.1158/1078-0432.CCR-07-4905. Epub 2008 Aug 11.

26.

Aspirin, COX-2, and the risk of colorectal cancer.

Benelli R.

N Engl J Med. 2007 Aug 23;357(8):824-5; author reply 824-5. No abstract available.

PMID:
17715417
27.
28.

Angiogenesis and cancer prevention: a vision.

Noonan DM, Benelli R, Albini A.

Recent Results Cancer Res. 2007;174:219-24. Review.

PMID:
17302199
29.

Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis.

Dell'Aica I, Niero R, Piazza F, Cabrelle A, Sartor L, Colalto C, Brunetta E, Lorusso G, Benelli R, Albini A, Calabrese F, Agostini C, Garbisa S.

J Pharmacol Exp Ther. 2007 May;321(2):492-500. Epub 2007 Feb 8.

PMID:
17289834
30.

Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression.

Larghero P, Venè R, Minghelli S, Travaini G, Morini M, Ferrari N, Pfeffer U, Noonan DM, Albini A, Benelli R.

Carcinogenesis. 2007 May;28(5):1008-20. Epub 2006 Nov 24.

PMID:
17127716
31.

Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates.

Tettamanti G, Malagoli D, Benelli R, Albini A, Grimaldi A, Perletti G, Noonan DM, de Eguileor M, Ottaviani E.

Curr Med Chem. 2006;13(23):2737-50. Review.

PMID:
17073625
32.

Cytokines and chemokines as regulators of angiogenesis in health and disease.

Benelli R, Lorusso G, Albini A, Noonan DM.

Curr Pharm Des. 2006;12(24):3101-15. Review.

PMID:
16918437
33.

Tumor inflammatory angiogenesis and its chemoprevention.

Albini A, Tosetti F, Benelli R, Noonan DM.

Cancer Res. 2005 Dec 1;65(23):10637-41. Review.

34.

The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.

Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.

Int J Oncol. 2005 Jul;27(1):223-35.

PMID:
15942664
35.

Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.

Bachmeier BE, Albini A, Vené R, Benelli R, Noonan D, Weigert C, Weiler C, Lichtinghagen R, Jochum M, Nerlich AG.

Exp Cell Res. 2005 Apr 15;305(1):83-98.

PMID:
15777790
36.

N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.

Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A.

Bioorg Med Chem Lett. 2005 Mar 1;15(5):1321-6.

PMID:
15713379
37.

Bladder cell culture on small intestinal submucosa as bioscaffold: experimental study on engineered urothelial grafts.

Campodonico F, Benelli R, Michelazzi A, Ognio E, Toncini C, Maffezzini M.

Eur Urol. 2004 Oct;46(4):531-7.

PMID:
15363573
38.

The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes.

Albini A, Benelli R, Noonan DM, Brigati C.

Int J Dev Biol. 2004;48(5-6):563-71. Review.

39.

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.

Fassina G, Venè R, Morini M, Minghelli S, Benelli R, Noonan DM, Albini A.

Clin Cancer Res. 2004 Jul 15;10(14):4865-73.

40.

New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2).

Rossello A, Nuti E, Orlandini E, Carelli P, Rapposelli S, Macchia M, Minutolo F, Carbonaro L, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A.

Bioorg Med Chem. 2004 May 1;12(9):2441-50.

PMID:
15080939
41.

Allele-specific patterns of the mouse parathyroid hormone-related protein: influences on cell adhesion and migration.

Benelli R, Peissel B, Manenti G, Gariboldi M, Vanzetto C, Albini A, Dragani TA.

Oncogene. 2003 Oct 30;22(49):7711-5.

PMID:
14586397
42.

Neutrophils and angiogenesis: potential initiators of the angiogenic cascade.

Benelli R, Albini A, Noonan D.

Chem Immunol Allergy. 2003;83:167-81. Review. No abstract available.

PMID:
12947984
43.

Simple method for in vitro bladder urothelium regeneration on a heterologous acellular matrix.

Campodonico F, Michelazzi A, Benelli R, Toncini C.

Pediatr Surg Int. 2003 Jul;19(5):415-6. Epub 2003 Jul 18. No abstract available.

PMID:
12883854
44.

The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression.

Guenzi E, Töpolt K, Lubeseder-Martellato C, Jörg A, Naschberger E, Benelli R, Albini A, Stürzl M.

EMBO J. 2003 Aug 1;22(15):3772-82.

45.

Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate.

Pezzato E, Donà M, Sartor L, Dell'Aica I, Benelli R, Albini A, Garbisa S.

J Leukoc Biol. 2003 Jul;74(1):88-94.

PMID:
12832446
46.

Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives.

Bisacchi D, Benelli R, Vanzetto C, Ferrari N, Tosetti F, Albini A.

Cancer Detect Prev. 2003;27(3):229-38. Review.

PMID:
12787731
47.

Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.

Giunti D, Borsellino G, Benelli R, Marchese M, Capello E, Valle MT, Pedemonte E, Noonan D, Albini A, Bernardi G, Mancardi GL, Battistini L, Uccelli A.

J Leukoc Biol. 2003 May;73(5):584-90.

PMID:
12714572
48.

Antiangiogenic activity of chemopreventive drugs.

Pfeffer U, Ferrari N, Morini M, Benelli R, Noonan DM, Albini A.

Int J Biol Markers. 2003 Jan-Mar;18(1):70-4. Review.

PMID:
12699068
49.

Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis.

Donà M, Dell'Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S.

J Immunol. 2003 Apr 15;170(8):4335-41.

50.

The angiogenic switch in solid tumors: clinical implications.

Tosetti F, Benelli R, Albini A.

Suppl Tumori. 2002 Nov-Dec;1(6):S9-11. Review. No abstract available.

PMID:
12658894

Supplemental Content

Loading ...
Support Center